Federal Register / Vol. 90, No. 27 / Tuesday, February 11, 2025 / Rules and Regulations 9289 

(4) This AD requires replacing Note 1 of 

EASA AD 2024–0247 with ‘‘If no approved 

instructions are provided within the 

compliance time of paragraph (1) of this AD, 

paragraph (2) of this AD must be 

accomplished before further flight. The 

affected part is eligible to be considered a 

serviceable part based on the content of the 

Collins Aerospace approved instructions, 

once received and accomplished, as required 

in paragraph (1) of this AD.’’ 

(5) This AD does not adopt the ‘‘Remarks’’ 

section of EASA AD 2024–0247. 

(i) Additional AD Provisions 

The following provisions also apply to this 

AD: 

(1) Alternative Methods of Compliance 

(AMOCs): The Manager, AIR–520, Continued 

Operational Safety Branch, FAA, has the 

authority to approve AMOCs for this AD, if 

requested using the procedures found in 14 

CFR 39.19. In accordance with 14 CFR 39.19, 

send your request to your principal inspector 

or responsible Flight Standards Office, as 

appropriate. If sending information directly 

to the manager of the Continued Operational 

Safety Branch, send it to the attention of the 

person identified in paragraph (j) of this AD 

and email to: AMOC@faa.gov. Before using 

any approved AMOC, notify your appropriate 

principal inspector, or lacking a principal 

inspector, the manager of the responsible 

Flight Standards Office. 

(2) Contacting the Manufacturer: For any 

requirement in this AD to obtain instructions 

from a manufacturer, the instructions must 

be accomplished using a method approved 

by the Manager, AIR–520, Continued 

Operational Safety Branch, FAA; or EASA; or 

Airbus SAS’s EASA Design Organization 

Approval (DOA). If approved by the DOA, 

the approval must include the DOAauthorized signature. 

(j) Additional Information 

For more information about this AD, 

contact Timothy Dowling, Aviation Safety 

Engineer, FAA, 2200 South 216th St., Des 

Moines, WA 98198; phone 206–231–3667; 

email timothy.p.dowling@faa.gov. 

(k) Material Incorporated by Reference 

(1) The Director of the Federal Register 

approved the incorporation by reference of 

the material listed in this paragraph under 5 

U.S.C. 552(a) and 1 CFR part 51. 

(2) You must use this material as 

applicable to do the actions required by this 

AD, unless this AD specifies otherwise. 

(i) European Union Aviation Safety Agency 

(EASA) AD 2024–0247, dated December 18, 

2024. 

(ii) Collins Aerospace Vendor Service 

Information Letter FA3T1–27–04, dated 

August 6, 2024. 

(3) For EASA material identified in this 

AD, contact EASA, Konrad-Adenauer-Ufer 3, 

50668 Cologne, Germany; telephone +49 221 

8999 000; email ADs@easa.europa.eu; 

website easa.europa.eu. You may find this 

material on the EASA website at 

ad.easa.europa.eu. 

(4) For Collins Aerospace material 

identified in this AD, contact Collins 

Aerospace, Customer Support Center, 2730 

West Tyvola Road, Charlotte, NC 28217; 

telephone 860–654–2500; email 

publications@collins.com; website 

customers.collinsaerospace.com. 

(5) You may view this material at the FAA, 

Airworthiness Products Section, Operational 

Safety Branch, 2200 South 216th St., Des 

Moines, WA. For information on the 

availability of this material at the FAA, call 

206–231–3195. 

(6) You may view this material at the 

National Archives and Records 

Administration (NARA). For information on 

the availability of this material at NARA, 

visit www.archives.gov/federal-register/cfr/ 

ibr-locations or email fr.inspection@nara.gov. 

Issued on February 4, 2025. 

Peter A. White, 

Deputy Director, Integrated Certificate 

Management Division, Aircraft Certification 

Service. 

[FR Doc. 2025–02494 Filed 2–7–25; 11:15 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

45 CFR Part 162 

[CMS–0056–F2] 

RIN 0938–AU19 

Administrative Simplification: 

Modifications of Health Insurance 

Portability and Accountability Act of 

1996 (HIPAA) National Council for 

Prescription Drug Programs (NCPDP) 

Retail Pharmacy Standards; and 

Modification of the Medicaid Pharmacy 

Subrogation Standard; Delay of 

Effective Date 

AGENCY: Office of the Secretary, 

Department of Health and Human 

Services (HHS). 

ACTION: Final rule; delay of effective 

date. 

SUMMARY: In accordance with the 

Presidential memorandum of January 

20, 2025, titled ‘‘Regulatory Freeze 

Pending Review,’’ the effective date of 

the final rule titled ‘‘Administrative 

Simplification: Modifications of Health 

Insurance Portability and 

Accountability Act of 1996 (HIPAA) 

National Council for Prescription Drug 

Programs (NCPDP) Retail Pharmacy 

Standards; and Modification of the 

Medicaid Pharmacy Subrogation 

Standard’’ is delayed until April 14, 

2025. That final rule adopted updated 

versions of the retail pharmacy 

standards for electronic transactions 

adopted under the Administrative 

Simplification subtitle of HIPAA, which 

constitute modifications to the adopted 

standards for the following retail 

pharmacy transactions: health care 

claims or equivalent encounter 

information; eligibility for a health plan; 

referral certification and authorization; 

and coordination of benefits. It also 

adopted a modification to the standard 

for the Medicaid pharmacy subrogation 

transaction. 

DATES: 

Effective date: The final rule titled 

‘‘Administrative Simplification: 

Modifications of Health Insurance 

Portability and Accountability Act of 

1996 (HIPAA) National Council for 

Prescription Drug Programs (NCPDP) 

Retail Pharmacy Standards; and 

Modification of the Medicaid Pharmacy 

Subrogation Standard,’’ which appeared 

in the December 13, 2024, Federal 

Register (89 FR 100763) is delayed to 

April 14, 2025. The incorporation by 

reference of certain publications 

adopted in the rule and approved by the 

Director of the Federal Register is also 

delayed to April 14, 2025. 

Compliance Date: The compliance 

dates are extended to April 14, 2028. 

FOR FURTHER INFORMATION CONTACT: 

Geanelle G. Herring, (410) 786–4466. 

Christopher S. Wilson, (410) 786–3178. 

SUPPLEMENTARY INFORMATION: Under 5 

U.S.C. 553(b) of the Administrative 

Procedure Act (APA), the agency is 

required to publish a notice of proposed 

rulemaking in the Federal Register 

before the provisions of a rule take 

effect. In addition, section 553(d) of the 

APA mandates a 30-day delay in the 

effective date after issuance or 

publication of a rule. However, to the 

extent that 5 U.S.C. 553 applies to this 

action, it is exempt from such 

requirements because it constitutes a 

rule of procedure under 5 U.S.C. 

553(b)(A). 

Alternatively, HHS’s implementation 

of this action without opportunity for 

public comment, effective immediately, 

is based on the good cause exceptions 

in 5 U.S.C. 553(b)(B) and (d)(3). Seeking 

public comment is impracticable, 

unnecessary, and contrary to the public 

interest. The temporary delay in the 

effective date until April 14, 2025, is 

necessary to give agency officials the 

opportunity for further review and 

consideration of the new regulation, 

consistent with the memorandum 

described previously. Given the 

imminence of the effective date and the 

brief length of the extension of the 

effective date, seeking prior public 

comment on this temporary delay 

would have been impracticable, as well 

as contrary to the public interest in the 

orderly promulgation and 

implementation of regulations. HHS 

also believes that affected entities need 


KHAMMOND on DSK9W7S144PROD with RULES
9290 Federal Register / Vol. 90, No. 27 / Tuesday, February 11, 2025 / Rules and Regulations 

to be informed as soon as possible of the 

extension and its length in order to plan 

and adjust their implementation process 

accordingly. 

Moreover, we are cognizant that the 

final rule that appeared in the December 

13, 2024, Federal Register (89 FR 

100763) requires publication in the 

Federal Register of a correction 

document as a technical error was made 

in the calculation of the date of the 8- 

month transition period prior to full 

compliance with the retail pharmacy 

and Medicaid pharmacy subrogation 

standards. References in that final rule 

to August 11, 2027 should, instead, read 

June 11, 2027. The delay by virtue of 

this final rule will permit more time to 

publish those corrections, while also 

signaling the nature of those 

forthcoming corrections, thereby 

minimizing public confusion. 

Consistent with the Presidential 

memorandum of January 20, 2025, 

‘‘Regulatory Freeze Pending Review’’, 

we are postponing for 60 days the 

effective date of the final rule that 

appeared in the December 13, 2024, 

Federal Register (89 FR 100763), for the 

purpose of reviewing any questions of 

fact, law, and policy. As a result, 

undertaking notice and comment 

procedures for this rule is unnecessary 

and contrary to the public interest, and 

we find good cause to waive the notice 

and comment requirements and the 30- 

day delay in the effective date. Based on 

these findings, this rule is effective 

immediately upon publication in the 

Federal Register. 

Dorothy A. Fink, 

Acting Secretary, Department of Health and 

Human Services. 

[FR Doc. 2025–02511 Filed 2–10–25; 8:45 am] 

BILLING CODE 4120–01–P 


KHAMMOND on DSK9W7S144PROD with RULES